Escitalopram Oxalate Patent Expiration
Escitalopram Oxalate was first introduced by Abbvie Inc
Escitalopram Oxalate Patents
Given below is the list of patents protecting Escitalopram Oxalate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lexapro |
US6916941 (Pediatric) | Crystalline composition containing escitalopram |
Feb 12, 2023
(Expired) | Abbvie |
| Lexapro |
US7420069 (Pediatric) | Crystalline composition containing escitalopram |
Feb 12, 2023
(Expired) | Abbvie |
| Lexapro | US6916941 | Crystalline composition containing escitalopram |
Aug 12, 2022
(Expired) | Abbvie |
| Lexapro | US7420069 | Crystalline composition containing escitalopram |
Aug 12, 2022
(Expired) | Abbvie |
Escitalopram Oxalate's Family Patents
Explore Our Curated Drug Screens
Escitalopram Oxalate Generic API Manufacturers
Several generic applications have been filed for Escitalopram Oxalate. The first generic version for Escitalopram Oxalate was by Norvium Bioscience Llc and was approved on Jul 31, 2007. And the latest generic version is by Amneal Pharmaceuticals and was approved on May 17, 2017.
Given below is the list of companies who have filed for Escitalopram Oxalate generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
2. AIPING PHARM INC
Aiping Pharmaceutical Inc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Sep 12, 2012 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 12, 2012 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Sep 12, 2012 |
3. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 4 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/5ML | solution | Prescription | ORAL | AA | Mar 14, 2012 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | May 17, 2017 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | May 17, 2017 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | May 17, 2017 |
4. ANTRIM PHARMS LLC
Antrim Pharmaceuticals Llc has filed for 1 generic for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Antrim Pharms Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/5ML | solution | Discontinued | ORAL | N/A | May 26, 2015 |
5. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/5ML | solution | Prescription | ORAL | AA | Apr 2, 2012 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 1 generic for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/5ML | solution | Prescription | ORAL | AA | Jun 12, 2013 |
7. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
8. ESJAY PHARMA
Esjay Pharma Llc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Esjay Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | May 14, 2015 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | May 14, 2015 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | May 14, 2015 |
9. GRAVITI PHARMS
Graviti Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
10. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/5ML
(reference standard) | solution | Prescription | ORAL | AA | Jun 12, 2012 |
11. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Sep 11, 2012 |
12. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
13. JUBILANT CADISTA
Jubilant Cadista Pharmaceuticals Inc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 12, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 12, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 12, 2012 |
Manufacturing Plant Locations New
Jubilant Cadista's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Jubilant Cadista as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
14. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 5MG BASE/5ML | solution | Prescription | ORAL | AA | Mar 31, 2016 |
15. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Jul 31, 2007 |
| EQ 20MG BASE | capsule | Discontinued | ORAL | N/A | Jul 31, 2007 |
| EQ 5MG BASE | capsule | Discontinued | ORAL | N/A | Jul 31, 2007 |
16. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Aug 28, 2015 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Aug 28, 2015 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Aug 28, 2015 |
17. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/5ML | solution | Prescription | ORAL | AA | May 3, 2012 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||
18. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Mar 14, 2012 |
| EQ 20MG BASE | tablet | Discontinued | ORAL | N/A | Mar 14, 2012 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Mar 14, 2012 |
19. TORRENT PHARMS LTD
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
20. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 3 different strengths of generic version for Escitalopram Oxalate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
| EQ 20MG BASE | tablet | Prescription | ORAL | AB | Sep 11, 2012 |
Manufacturing Plant Locations New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||